Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

751 studies match

clinicaltrialsPublishedShowing 251–300 of 751 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03519971	Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer	completed	Phase 3	328	AstraZenecaINDUSTRY	14	Jul 14, 2026	clinicaltrials
NCT06112379	A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer	active not recruiting	Phase 3	1,902	AstraZenecaINDUSTRY	26	Jul 13, 2026	clinicaltrials